Mitapivat

The latest news about Mitapivat: headlines, AI summaries and the full story from every source.

Four High-Risk Stocks With Potential for Significant Returns Motley Fool · October 14, 2026, 10:08 UTC
Agios Pharmaceuticals Stock Rises on FDA Priority Review for Mitapivat in Sickle Cell Disease Yahoo Finance · July 7, 2026, 16:52 UTC
Agios Pharmaceuticals Q1 Earnings Report and Pipeline Updates Yahoo Finance · April 29, 2026, 14:20 UTC
Agios Reports Q1 2026 Earnings Results with Strong Revenue Growth Motley Fool · April 30, 2026, 14:48 UTC